LANZA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 9.604
EU - Europa 3.038
AS - Asia 1.252
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
AF - Africa 2
Totale 13.916
Nazione #
US - Stati Uniti d'America 9.598
PL - Polonia 1.067
CN - Cina 798
UA - Ucraina 534
IT - Italia 497
DE - Germania 337
TR - Turchia 267
GB - Regno Unito 249
FI - Finlandia 128
VN - Vietnam 115
SE - Svezia 111
FR - Francia 47
HK - Hong Kong 19
BE - Belgio 18
RU - Federazione Russa 15
IN - India 14
ES - Italia 12
JP - Giappone 12
AU - Australia 7
CA - Canada 6
TW - Taiwan 6
IR - Iran 5
CZ - Repubblica Ceca 4
EU - Europa 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AT - Austria 3
MD - Moldavia 3
NL - Olanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BR - Brasile 2
GR - Grecia 2
IE - Irlanda 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
SG - Singapore 1
Totale 13.916
Città #
Fairfield 1.508
Woodbridge 1.119
Warsaw 1.066
Houston 931
Ashburn 634
Jacksonville 622
Wilmington 617
Seattle 563
Chandler 537
Ann Arbor 517
Cambridge 487
Princeton 312
Izmir 186
Nanjing 186
Beijing 172
Milan 157
San Diego 156
Dong Ket 115
Boardman 70
Nanchang 61
Shenyang 57
Falls Church 50
New York 46
Redwood City 45
Bremen 44
Shanghai 43
Hebei 39
London 39
Ferrara 36
Norwalk 35
Changsha 33
Jiaxing 33
Mountain View 31
Tianjin 25
Dearborn 22
Kunming 20
Rome 20
Hong Kong 19
Jinan 19
Zhengzhou 17
Brussels 16
San Mateo 16
Chicago 15
Ningbo 14
Addison 13
Guangzhou 13
Helsinki 13
Redmond 11
Faenza 10
Orange 10
Taizhou 10
Washington 10
Wuhan 10
Auburn Hills 9
Lanzhou 9
Hounslow 8
Kilburn 8
Parma 8
Chiswick 7
Des Moines 7
Düsseldorf 7
Los Angeles 7
Verona 7
Bologna 6
Haikou 6
Saint Louis 6
Augusta 5
Florence 5
Mestre 5
Siena 5
Acton 4
Barcelona 4
Genoa 4
Hangzhou 4
Monmouth Junction 4
Philadelphia 4
Tappahannock 4
Tokyo 4
Arcadia 3
Auckland 3
Bangalore 3
Casapesenna 3
Chisinau 3
Indiana 3
Messina 3
Monselice 3
Munich 3
New Taipei 3
Prescot 3
Santa Maria Di Sala 3
Battipaglia 2
Beckley 2
Breganze 2
Brussel 2
Catania 2
Changchun 2
Chengdu 2
Dallas 2
Deiva Marina 2
Fuzhou 2
Totale 11.053
Nome #
Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery 187
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 185
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 183
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 160
PCR con primer degenerati non evidenza sequenze virali di HHV8 nè di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 150
null 142
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 139
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 137
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 135
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 132
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 127
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 126
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 123
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 120
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 120
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 117
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 117
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 116
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 114
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 113
CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation 111
RABBIT IgG ANTIBODIES AGAINST CORD RED BLOOD CELL MEMBRANES BIND TO COMPLEMENT RECEPTOR 1 (CD35) 109
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 109
Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. 108
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 105
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia 105
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 103
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 101
CXCR-4 Expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies 100
CD34+CD33+ blast cells: Correlation with FAB subtypes 99
Immunosuppressive properties of mesenchymal stromal cells 99
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 97
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach 95
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics 95
BCR-ABL rearrangement is not detectable in essential thrombocythemia 92
Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts 91
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 90
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review 89
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis. 87
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients 86
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 86
null 85
Autologous stem cell transplantation: is it still relevant in breast cancer? 84
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 83
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 81
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 80
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 79
null 77
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 76
Assessment of growth of endothelial cells and fibroblasts in long-term cultures of patients with haematological malignancies. 76
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? 74
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 74
Bone marrow stromal cells in acute promyelocytic leukaemia: comparison with other acute myelogenous leukaemia subtypes. 73
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen 72
Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT) 72
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 72
null 71
Assessment of bone marrow-derived endothelial cells in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation 70
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database 70
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia 70
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation 70
Adverse haematological effects of ticlopidine. A report of four cases 69
Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at? 69
Differences among young adults, adults and elderly chronic myeloid leukemia patients 68
Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection. 67
Move on air: Webinar for education in stem cells mobilization Report I 66
Photomultiplier voltage setting: Possible important source of variability in molecular equivalents of soluble fluorochrome (MESF) calculation? 65
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry 64
Novel Applications for the Flow Cytometry 64
In vitro expansion and immunophenotypic characterization of circulating stem celle in patients affected by systemic scleoris (SSc): possible implications in fibrosis process 63
p53 exon 5 mutation in two cases of leukemic mantle cell lymphoma 62
Sources and procurements of HSC 62
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: A 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT) 62
null 61
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study 61
Long term cultured bone marrow cell from multiple myloma patients give rise to higher number of endothelial colonies than MGUS patients and normal controls 60
Human bone marrow endothelial-colony growth before and after stem cell transplantation in non-hodgkin’s lymphoma patients. 60
Is allogeneic transplant for solid tumors still alive? 60
Chlamydia trachomatis and Ocular Lynphoma. a possible link? 59
Correlation between doses of CD34+ cell subsets infused, number of long-term culture colony forming cells and kinetics of engrafment in patients receiving autologous peripheral blood stem cell transplant 59
Eterogeneita’ immunofenotipica di cellule staminali mesenchimali dopo espansione ex vivo 59
Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants 59
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 59
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 59
Multicolor analysis of bone marrow stromal cells from normal and leukemic patients 58
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 58
Citometria a flusso: applicazioni in ematologia 57
Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually 57
Production of solubile HLA-G antigens by bone marrow - derived human mesenchimal cells (B-MSCS) has a role in the inhibition of the lymphoproliferative response. 56
Trapianto autologo di cellule staminali in paziente affetta da sclerosi sistemica a varietà diffusa. 56
Cytofluorimetric analysis of cytokine receptors in blast cells from acute leukemia. 56
Cellule mesenchimali stromali: caratterizzazione immunofenotipica e funzionale 56
Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report 56
Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma 56
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 55
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model 55
Functional and immunophenotypic characteristics of isolated CD105+ and fibroblasts+ mesenchymal cells from acute myeloid leukaemia: implication for their plasticity along endothelial lineage 53
Production of soluble HLA-G antigens is involved in the inhibition of lymphoproliferative response by human mesenchymal stromal cells (MSC) from different sources 53
Distribution of human bone marrow endothelial-colony growth in acute myeloid leuKemia patients. 53
null 53
Totale 8.634
Categoria #
all - tutte 72.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.481
Totale 74.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019609 0 0 0 0 0 0 0 0 0 0 170 439
2019/20202.785 376 44 40 227 89 216 118 183 583 482 278 149
2020/20214.512 332 356 315 315 361 521 180 437 112 722 666 195
2021/20222.419 198 348 74 131 75 80 123 169 110 284 151 676
2022/20231.650 306 54 71 265 216 207 55 144 177 21 84 50
2023/2024512 87 89 61 35 52 67 25 50 27 18 1 0
Totale 14.604